| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/GCC.22085 |
| P698 | PubMed publication ID | 23929716 |
| P50 | author | Boris Zhivotovsky | Q30158891 |
| Weng-Onn Lui | Q30504225 | ||
| Lovisa Lundholm | Q57959356 | ||
| P2093 | author name string | Ana Zovko | |
| Kristina Viktorsson | |||
| Petra Hååg | |||
| Rolf Lewensohn | |||
| Lena Kanter | |||
| Hogir Salim | |||
| Luigi de Petris | |||
| Alexandros Arvanitis | |||
| Deniz Mahmut Özata | |||
| P2860 | cites work | The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A | Q22009032 |
| WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis | Q24310644 | ||
| Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors | Q24614112 | ||
| Twist-1 regulates the miR-199a/214 cluster during development | Q24652478 | ||
| The basics of epithelial-mesenchymal transition | Q24652992 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| A synthetic lethal interaction between K-Ras oncogenes and Cdk4 unveils a therapeutic strategy for non-small cell lung carcinoma. | Q27851572 | ||
| Prediction of mammalian microRNA targets | Q27860498 | ||
| Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 | Q29617043 | ||
| ERBB receptors and cancer: the complexity of targeted inhibitors | Q29619520 | ||
| LKB1 modulates lung cancer differentiation and metastasis | Q30080027 | ||
| Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer | Q33915005 | ||
| MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma. | Q34409807 | ||
| Comparative analysis of dynamic cell viability, migration and invasion assessments by novel real-time technology and classic endpoint assays | Q34456201 | ||
| Protein secretion is required for pregnancy-associated plasma protein-A to promote lung cancer growth in vivo | Q34477488 | ||
| Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study | Q34798314 | ||
| microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C. | Q34993968 | ||
| Genomic loss of the putative tumor suppressor gene E2A in human lymphoma. | Q35144578 | ||
| Decreased microRNA-214 levels in breast cancer cells coincides with increased cell proliferation, invasion and accumulation of the Polycomb Ezh2 methyltransferase | Q35478969 | ||
| Detection of the argonaute protein Ago2 and microRNAs in the RNA induced silencing complex (RISC) using a monoclonal antibody | Q35878451 | ||
| MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7. | Q35922278 | ||
| A biochemical approach to identifying microRNA targets | Q36288545 | ||
| The microRNA (miR)-199a/214 cluster mediates opposing effects of progesterone and estrogen on uterine contractility during pregnancy and labor | Q36367173 | ||
| MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma | Q36394758 | ||
| The database of experimentally supported targets: a functional update of TarBase | Q37202497 | ||
| HIF2alpha cooperates with RAS to promote lung tumorigenesis in mice | Q37286696 | ||
| miRNAs in lung cancer: large roles for small players | Q37932539 | ||
| Role of adjuvant chemotherapy in NSCLC (stages I to III). | Q37944014 | ||
| Response and resistance to NF-κB inhibitors in mouse models of lung adenocarcinoma | Q38256553 | ||
| Genetic downregulation of pregnancy-associated plasma protein-A (PAPP-A) by bikunin reduces IGF-I-dependent Akt and ERK1/2 activation and subsequently reduces ovarian cancer cell growth, invasion and metastasis | Q38344803 | ||
| Expression of pregnancy-associated plasma protein-A (PAPP-A) during human villous trophoblast differentiation in vitro. | Q38354670 | ||
| miRNA-214 modulates radiotherapy response of non-small cell lung cancer cells through regulation of p38MAPK, apoptosis and senescence | Q39289196 | ||
| MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer. | Q39352889 | ||
| Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer. | Q39460209 | ||
| c-Raf, but not B-Raf, is essential for development of K-Ras oncogene-driven non-small cell lung carcinoma | Q39554370 | ||
| Overexpression of pregnancy-associated plasma protein-A in ovarian cancer cells promotes tumor growth in vivo | Q39595849 | ||
| Zonal differences in meniscus matrix turnover and cytokine response. | Q42497022 | ||
| Purification of RNA using TRIzol (TRI reagent). | Q43048322 | ||
| Relationship between pregnancy-associated plasma protein-A and lung cancer | Q48011420 | ||
| Autoregulation of phospholipase D activity is coupled to selective induction of phospholipase D1 expression to promote invasion of breast cancer cells. | Q53470628 | ||
| Plexin-B1 is a target of miR-214 in cervical cancer and promotes the growth and invasion of HeLa cells | Q83153641 | ||
| P433 | issue | 10 | |
| P921 | main subject | non-small-cell lung carcinoma | Q3658562 |
| neoplastic invasiveness | Q112498967 | ||
| P304 | page(s) | 895-911 | |
| P577 | publication date | 2013-08-09 | |
| P1433 | published in | Genes, Chromosomes and Cancer | Q5532697 |
| P1476 | title | miRNA-214 is related to invasiveness of human non-small cell lung cancer and directly regulates alpha protein kinase 2 expression | |
| P478 | volume | 52 |
| Q27346392 | A novel neutralizing antibody targeting pregnancy-associated plasma protein-a inhibits ovarian cancer growth and ascites accumulation in patient mouse tumorgrafts |
| Q26740327 | A potential role for estrogen in cigarette smoke-induced microRNA alterations and lung cancer |
| Q35768464 | DKK1 is a potential novel mediator of cisplatin-refractoriness in non-small cell lung cancer cell lines |
| Q91903029 | Differential prognostic impact of platelet-derived growth factor receptor expression in NSCLC |
| Q89433569 | Effects of Sepantronium Bromide (YM-155) on the Whole Transcriptome of MDA-MB-231 Cells: Highlight on Impaired ATR/ATM Fanconi Anemia DNA Damage Response |
| Q35927282 | Expression and clinicopathological significance of miR-193a-3p and its potential target astrocyte elevated gene-1 in non-small lung cancer tissues |
| Q33572235 | Indirect targeting of IGF receptor signaling in vivo by substrate-selective inhibition of PAPP-A proteolytic activity |
| Q44077895 | Integration of genomic, transcriptomic and functional profiles of aggressive osteosarcomas across multiple species |
| Q37679619 | MicroRNAs-role in lung cancer |
| Q38241121 | MicroRNAs: a new key in lung cancer |
| Q37678178 | PAPP-A: a promising therapeutic target for healthy longevity. |
| Q90405825 | Pregnancy-associated plasma protein a in cancer: expression, oncogenic functions and regulation |
| Q33720233 | Systems biology approaches to develop innovative strategies for lung cancer therapy |
| Q35690633 | The role of PAPP-A in the IGF system: location, location, location. |
| Q54222671 | Whole-exome sequencing reveals potential molecular predictors of relapse after discontinuation of the targeted therapy in chronic myeloid leukemia patients. |
| Q36629397 | microRNA-214 promotes epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting the suppressor-of-fused protein (Sufu) |
Search more.